FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Heart-Valve, Non-Allograft Tissue

PMA: P170006 · Supplement: S043 · Decision Apr 9, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P170006 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Heart-Valve, Non-Allograft Tissue
Trade Name
Avalus Bioprosthesis
PMA Number
P170006
Supplement Number
S043
Device Class
FDA Class 3
Product Code
LWR
Generic Name
heart-valve, non-allograft tissue
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
April 9, 2026
Date Received
March 12, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

extension of the slaughter-to-receipt timeframe of shipped tissue

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LWR Heart-Valve, Non-Allograft Tissue